RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 109 filers reported holding RUBIUS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $289,000 | -43.0% | 52,432 | +0.1% | 0.00% | – |
Q4 2021 | $507,000 | -66.9% | 52,362 | -38.9% | 0.00% | -100.0% |
Q3 2021 | $1,532,000 | -54.3% | 85,709 | -37.5% | 0.00% | -50.0% |
Q2 2021 | $3,349,000 | +39.4% | 137,179 | +51.3% | 0.00% | +100.0% |
Q1 2021 | $2,403,000 | +560.2% | 90,668 | +89.1% | 0.00% | – |
Q4 2020 | $364,000 | +85.7% | 47,959 | +22.3% | 0.00% | – |
Q3 2020 | $196,000 | -29.7% | 39,209 | -15.9% | 0.00% | – |
Q2 2020 | $279,000 | +381.0% | 46,644 | +257.5% | 0.00% | – |
Q1 2020 | $58,000 | -62.8% | 13,047 | -20.4% | 0.00% | – |
Q4 2019 | $156,000 | – | 16,385 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |